Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - sildenafil oral dosing in vivo data at rat, mouse

ABSTRACT: sildenafil oral dosing to rat and mouse, plasma analysis data for in vivo metabolite ID. 48h used as blank plasma.

INSTRUMENT(S): 6530 QTOF/MS

ORGANISM(S): Mouse Rat

SUBMITTER: Junsang Yu

PROVIDER: MSV000085161 | GNPS | Thu Mar 26 01:17:00 GMT 2020

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

20231211_public_raw_data_invivo_sildenafil_metabolite

Project description:sildenafil oral dosing to rat and mouse, plasma analysis data for in vivo metabolite ID. 48h used as blank plasma. + 's' added prefix each raw data.

2023-12-11 | MSV000093627 | MassIVE

GNPS - 20231211_public_raw_data_invivo_sildenafil_metabolite

Project description:sildenafil oral dosing to rat and mouse, plasma analysis data for in vivo metabolite ID. 48h used as blank plasma. + 's' added prefix each raw data.

2023-12-11 | MSV000093627 | GNPS

Oral dosing for antenatal corticosteroids in the rhesus macaque

Project description:Purpose: Evaluated the transcriptional effects of an effective oral dosing of antental corticosteroids using betamethasone-phophate compared to the clinical treatment with the combination drug betamethasone-phosphate+betamethasone-acetate for fetal lung maturation. Methods: RNA-sequencing of the fetal hippocampus, liver and lung was done. Differential expression analysis was done using read counts. Results: There were no significant differences between oral Beta-P and the clinical treatment in the fetal hippocampus. Small differences were detected in the fetal lung associated with cellular proliferation and in the fetal liver. Conclusions: Oral betamethasone-phosphate is an effective oral treatment that does not cause toxic effect in the fetal brain despite the higher dose.

2019-09-25 | GSE131194 | GEO

Gene Expression during Panobinostat Dosing

Project description:A clinical study evaluating the dosing of an oral HDACi panobinostat in patient infected with HIV-1. Dosing was 20 mg orally, 3 times weekly, every other week for a total of 8 weeks. Gene expression was evaluated in whole PBMCs at baseline (Visit 2), after 3 doses (Visit 4), 4 weeks after dosing (Visit 12) and 6 months after dosing (Visit 13) using the Affymetrix HTA 2.0 gene expression chip

2018-01-30 | GSE109792 | GEO

Open TG-GATEs (in vivo repeat dosing)

Project description:The Toxicogenomics Project was a 5-year collaborative project (2002-2007) by a consortium comprising the Japanese government and several pharmaceutical companies. The project produced the 'Toxicogenomics Project-Genomics Assisted Toxicity Evaluation system' (TG-GATEs), a large-scale database of transcriptomics and pathology data potentially useful for predicting the toxicity of new chemical entities. Conventional in vivo toxicology data was collected from single dose and repeat dosing studies on rats, and gene expression measured for the liver (and kidney in some cases). To provide information on species differences, gene expression was also measured in rat and human hepatocytes treated with the chemicals in vitro. Approximately 130 chemicals, primarily medicinal compounds, were tested at multipe doses. Gene expression was analysed using Affymetrix GeneChip arrays. The gene expression data has been submitted in four parts: in vivo single dose (E-MTAB-799), in vivo repeat dosing, in vitro rat (E-MTAB-797) and in vitro human (E-MTAB-798). This submission comprises the in vivo, repeat dosing studies. If publishing results based on this data, please cite the full project name 'Toxicogenomics Project and Toxicogenomics Informatics Project', the database name 'Open TG-GATEs' and the URL 'http://toxico.nibio.go.jp'. Please note that the European Bioinformatics Institute (EBI) was not involved in the Toxicogenomics Project in any way, acting only to submit the transcriptomics data to Array Express. Queries about the project can be addressed to the consortium directly via 'opentggates@nibio.go.jp'. This dataset is part of the TransQST collection.

2012-02-10 | E-MTAB-800 | biostudies-arrayexpress

Pulsed dosing and extended daily dosing of oral vancomycin do not facilitate clearance of Clostridioides difficile colonization in mice

Project description:Pulsed dosing and extended daily dosing of oral vancomycin in mice

| PRJEB67315 | ENA

Oral dosing for antenatal corticosteroids in the rhesus macaque

Project description:Oral dosing for antenatal corticosteroids in the rhesus macaque

| PRJNA542881 | ENA

Gene expression changes in Porphyromonas gingivalis W83 after inoculation in rat oral cavity

Project description:The aim of this study is to investigate the alterations in gene expression in Porphyromonas gingivalis W83 after inoculation in rat oral cavity. P.gingivalis W83 inoculation in rat oral cavity caused inflammatory responses in gingival tissues and destroyed host alveolar bone. Microarray analysis revealed that 42 genes were upregulated, and 22 genes were downregulated in the detected 1786 genes in the inoculated P.gingivalis W83. Products of these upregulated and downregulated genes are mainly related to transposon functions, cell transmembrane transportation, protein and nucleic acid metabolism, energy metabolism, cell division and bacterial pathogenicity.P.gingivalis W83 has a pathogenic effect on host oral cavity. Meanwhile, inflammatory oral environment alters P.gingivalis W83 gene expression profile. These changes in gene expression may limit the proliferation and weaken the pathogenicity of P.gingivalis W83, and favor themselves to adapt local environment for survival.

2015-04-07 | GSE67608 | GEO

Differential gene expressions for androgen-induced benign prostatic hyperplysia rat underwent oral treatment of metabolic peptide ghrelin

Project description:To preliminary distinguish differential gene expressions in BPH-rat prostate after oral treatment of ghrelin.

2019-04-11 | GSE129561 | GEO

gnps- Actinomyces naeslundi oral isolate

Project description:Oral isolate grown anaerobically in SHI medium as described for project MassIVE ID: MSV000079151

2015-06-12 | MSV000079158 | MassIVE